On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Nanotag Biotechnologies GmbH's own share of each project, not the project's full budget.
- Horizon 2020€1.1M · 1 project
- Horizon Europe€515k · 1 project
Projects
2 EU-funded projects, newest first. Each links to the official record.
- LeadtoTreatPartner
Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€515ktheir share - IMAGEOMICSPartner
Imaging the proteome at the nanoscale
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
€1.1Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Kungliga Tekniska HoegskolanSweden · 1 shared project
- SINTEF ASNorway · 1 shared project
- Bar Ilan UniversityIsrael · 1 shared project
- Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen RechtsGermany · 1 shared project
- Narodowy Instytut LekowPoland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotics
- bacteriology
- proteins
- proteomics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.